United States · FDA National Drug Code directory
gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-867_2e493243-47c0-460e-bea9-4ed0261adf90
- Product NDC
- 16571-867
- Form
- CAPSULE
- Composition / generic term
- gabapentin
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220801
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (16571-867-01) · 16571-867-01
- 30 CAPSULE in 1 BOTTLE (16571-867-03) · 16571-867-03
- 1000 CAPSULE in 1 BOTTLE (16571-867-10) · 16571-867-10
- 500 CAPSULE in 1 BOTTLE (16571-867-50) · 16571-867-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →